UPLOAD CV

    Your sales manager is talented, and their proposal is strong. But somewhere along the way, something breaks. Customers feel oversold, technical details get lost, and the trust you spent months building gets dented.

    This is one of the most persistent problems in contract development and manufacturing (CDMO) commercial teams, and most leaders don’t realise the root cause is their CMDO sales model.

    The Problem

    The temptation in CDMO is to find one exceptional commercial person: someone who can open new accounts, navigate technical conversations, manage complex, long-term relationships, and close business across sales cycles spanning years. As anyone who has tried to hire or develop that profile knows, it rarely works.

    The global CDMO market is worth around $246 billion and is forecast to keep growing over the next decade. In a sector where a single account can run from Phase I through to commercial launch, a flawed commercial model compounds at every stage.

    I recently spoke with Michael Stanek, a Global API Commercial and Operations Executive Leader, on the Active Ingredient Podcast. With over 25 years in the CDMO sector, Michael has led turnarounds, integrated acquisitions, and spent much of his career examining why commercial and operations rarely pull in the same direction.

    His view is that the disconnect reflects how the two functions are built, not how the people within them behave. “It’s almost built into the system,” he told me. “The two functions operate on completely different time horizons, with different incentives, different pressures, and even different definitions of risks.”
    Commercial focuses on growth and relationships, while Operations focuses on capacity, compliance, and execution. As Michael puts it, commercials sell the future while operations protects the present.

    This cap creates friction. The expectation is that one salesperson can bridge it. “We pretend that the commercial person should magically… understand everything. The chemistry, the process of risk, the analytical readiness, regulatory… But these people don’t exist on the market, and especially not in this type of business.”

    The Solution: How To Fix Your CDMO Sales Model

    Step 1: Stop Designing Around a Profile That Doesn’t Exist

    Before Michael could redesign his commercial team, he had to challenge an assumption: that the right person, given enough support and development, can open new accounts and manage complex relationships with equal effectiveness.

    “Only a very small minority of people… genuinely embody both mindsets at the same time,” he told me. “We often argue that one person can be equally strong in opening new doors and in nurturing complex long-term relationships. But in reality, those profiles are extremely rare.”

    The problem compounds quietly. When a salesperson is heavily loaded with existing business, new business development slides to a secondary priority. In a sector where a customer relationship can run from Phase I through to commercial launch, that lag has serious consequences for the pipeline. “Future business will suffer if new growth is not nurtured in parallel,” Michael said.

    Designing a commercial team around a role that doesn’t reflect the reality of how people work is the starting point of the problem. The structural fix has to come first.

    Step 2: Divide the Role Into Two Complementary Functions

    Michael’s answer is the ‘dual sales model’. Rather than asking one person to carry the entire commercial relationship, he divides responsibility between a sales manager and a business manager.

    The sales manager handles the front end: identifying opportunities, managing the customer interface, and presenting the proposal. The business manager brings technical depth, site-specific knowledge, and a realistic understanding of what can be done. They represent a specific manufacturing site, build the proposal from the inside, and stay with the project once the business is won.

    Active Ingredients Podcast CTA

    RELATED: Learn From Leaders Who’ve Solved This

    Struggling with transformation, team building or leading through change? Active Ingredients features life science executives sharing the exact frameworks they used to navigate these challenges. Real strategies from leaders who’ve made it work.

    “The same business manager stays with the project,” Michael said, “ensuring continuity and credibility, while the sales manager can focus then on new opportunities.”

    In practice, Michael also brought cost calculation specialists into the commercial process at the proposal stage, so pricing and commitments reflected operational reality before they reached the customer. Once the business is won, the same people who made the commitments are accountable for delivery. There’s no gap between what was sold and who’s responsible for the outcome.

    Step 3: Replace Overselling with Technical Credibility

    Overselling in CDMO is rarely deliberate, but it’s damaging. When a salesperson lacks deep technical knowledge, they fill gaps with confidence rather than facts, and customers from a chemistry or process background quickly pick up on this.

    “Selling in our industry is not about charisma or persistence,” Michael said. “It requires deep technical understanding, operational willingness, and the ability to navigate uncertainty.”

    Michael has seen this pattern lead to lost business repeatedly. Customers don’t simply evaluate capability; they evaluate whether the person across the table understands their molecule. “The customer expects that you understand what’s going on with my baby,” he explained. “You have to speak the same language.”

    The business manager addresses this directly. With both roles in the room, technical questions get answered accurately. When Michael first introduced the model, some smaller biotech companies found the dual presence unexpected. He recalled that they “felt it was a little bit overengineered. Two people suddenly show up instead of one.” That quickly faded within a year. Customers began to see transparency where previously they experienced overselling, and a technical contact who understood their project rather than just their contract.

    The Evidence

    The shift in customer response came within a year. Expectations set during the sales process matched what operations could deliver, because the same team was responsible for both. Internal communication improved for the same reason. “By having the business manager and sales manager in the room together, the communication became transparent and credible,” Michael said.

    The commercial-operations tension didn’t disappear, but it had far less room to damage the customer relationship. “Creating trust upfront and accountability downstream,” Michael said. “That combination dramatically improved delivery and customer confidence.”

    Your Next Move

    If your CDMO commercial team is underperforming, the issue may be structural, not personal. Before changing people, examine your CDMO sales model.

    1. Is your pipeline actively growing, or has your best commercial person become too absorbed in existing accounts to develop new business?
    2. When a deal is won, does the person who built customer trust stay involved, or does the relationship get handed over to someone who wasn’t in the room?
    3. Can your commercial team answer deep technical questions during a sales conversation without overselling what the site can realistically deliver?
    4. If customers have reduced their volume or walked away from deals, did they feel technically understood, or just commercially managed?

     


     

    Michael’s full conversation on the Active Ingredients podcast covers further ground, including how he leads teams through business turnarounds, the cultural challenge of integrating big pharma sites into CDMO networks, and what the next generation of life sciences leaders needs to develop. Listen to the full episode.

    Fraser Dove International supports life sciences organisations in identifying commercial and operational leaders who understand both the science and the customer. If you’re building or reshaping a CDMO commercial team, we can help.

     


     

    Meet the Author

    Thomas Dove, CEO

    Thomas Dove is CEO and Co-Founder of Fraser Dove International. As host of the Active Ingredients podcast, Thomas interviews senior executives and industry pioneers to uncover the insights that drive successful life science organisations.

    Through his work in executive search and the hosting the Active Ingredients podcast, Thomas has developed deep expertise in identifying the leadership qualities that distinguish exceptional life science executives. He regularly writes about talent acquisition strategies, leadership development, and the evolving challenges facing C-suite professionals in the rapidly changing life sciences.

    Thomas is passionate about helping life science professionals navigate their career journeys and supporting organisations in building leadership teams that can drive innovation and growth. His insights stem from years of working closely with senior leaders across the pharmaceutical, biotechnology, and Medical Device industries.

    Outside the office, he champions family values, positive energy, and his beloved Chelsea FC.


     

    * This article is based on an interview from the Active Ingredients podcast. Hosted by Thomas Dove, the Active Ingredients Podcast dissects the very essence of exceptional leadership in the life sciences. Subscribe to the Active Ingredients podcast on Spotify, Apple Podcasts, Amazon Music and YouTube.

    Loved this article?

    Share it with your friends, family or your peers!